| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |